Chordoma Treatment in Turkey

What is Chordoma and What Are Its Symptoms?

Chordoma is a rare, slow-growing bone cancer developing from cellular remnants of the embryonic notochord—the primitive structure that forms the spine. During embryonic development, these cells normally regress. When they persist and become malignant, tumours emerge along the axial skeleton. Roughly half develop in the sacrum or coccyx, about one-third at the skull base (clivus), and the rest in the mobile cervical, thoracic, or lumbar spine.

Because chordomas grow indolently, symptoms often emerge gradually and depend on tumour location:

• Skull base (clival): Persistent headaches, double vision from cranial nerve compression, facial numbness, or swallowing difficulties.
• Mobile spine: Localised back or neck pain, nerve pain radiating into the arms or legs, numbness, or limb weakness.
• Sacral: Deep pelvic or lower back ache, numbness in the buttocks or groin, and progressive bowel or bladder dysfunction.

Specialised assessment within an oncology service is vital, as these tumours tend to recur locally if not completely addressed.

Diagnosing Chordoma: Hospital Tests and Essential Records

Accurate diagnosis demands precise imaging and histopathology. When presenting to a hospital in Turkey, patients undergo comprehensive assessments through check-ups and diagnostics units to define the tumour relative to nearby critical nerves and blood vessels.

Standard diagnostic investigations include:

• High-resolution MRI: Essential for evaluating soft-tissue extension, spinal cord involvement, and relationships to critical cranial or spinal vessels.
• Thin-slice CT scanning: Assesses bone destruction and tumour calcification, providing essential detail for surgical reconstruction.
• Biopsy and immunohistochemistry: Biopsies must be carefully planned to avoid seeding tumour cells. Pathologists confirm chordoma by identifying physaliferous cells and positive expression of the brachyury protein.
• Staging scans: Chest and abdominal CT scans verify whether distant spread has occurred, though metastases at diagnosis remain uncommon.

Patients travelling abroad should bring original DICOM imaging discs (MRI and CT), previous histopathology slides or paraffin blocks, surgical operation notes, and any prior radiotherapy reports.

Treatment Options for Chordoma

Standard chemotherapy is largely ineffective against chordoma. Consequently, management relies on surgical resection and high-dose, targeted radiation therapy. A multidisciplinary team spanning neurosurgery, orthopaedics, and radiation oncology assesses each patient individually.

Final treatment decisions are made by the treating clinical team following an in-depth review of diagnostic scans and anatomical feasibility.

Planning Your Treatment Journey in Turkey

Pursuing chordoma management abroad requires structured planning. Turkish clinical centres routinely perform remote file reviews before travel, where a tumour board evaluates your DICOM images to confirm whether resection or radiotherapy is appropriate.

Typical timelines include:

• Evaluation and consultation: 4 to 7 working days for repeat scans and multidisciplinary review.
• Surgical hospitalisation: 7 to 14 inpatient days, followed by 10 to 14 days of local recovery before flight clearance.
• Post-operative recovery: Patients undergoing spinal surgery frequently engage in inpatient rehabilitation to rebuild strength and gait.
• Radiation courses: Particle or stereotactic radiotherapy typically requires 6 to 8 weeks of outpatient visits.

Before departure, you will receive translated clinical summaries and digital imaging records to ensure your home doctors can maintain ongoing surveillance, typically requiring follow-up MRI scans every few months.

When International Travel is Not Advisable

Patients should never undertake medical travel without explicit clearance from a neurosurgeon or spinal specialist. Long-distance flights carry risks of deep vein thrombosis and clinical deterioration if neural structures are acutely compressed.

Seek immediate local emergency care and postpone overseas travel if you notice:

• Rapidly progressive weakness in the legs or arms, or sudden inability to walk.
• Sudden incontinence or urinary retention, indicative of spinal cord or cauda equina compression.
• Severe, escalating headaches accompanied by nausea, visual impairment, or confusion.
• Acute cranial nerve palsies, such as sudden swallowing difficulty or facial drooping.
• Uncontrolled spinal pain unmanaged by standard prescription analgesics.

In such circumstances, immediate local medical stabilising is essential before considering any international travel.